Cellular Biomedicine Group Initiates Patient Recruitment For...

Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced the initiation of patient recruitment to support a study of ReJoinTM human adipose derived mesenchymal progenitor cell therapy for Cartilage Damage resulting from osteoarthritis or sports injury. The study is based on the same science that has shown tremendous progress in the treatment of Knee Osteoarthritis .

http://ift.tt/1ImKCB8